[1]
|
子宫肌瘤的诊治中国专家共识专家组.子宫肌瘤的诊治中国专家共识[J].中华妇产科杂志, 2017, 52:793-800. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfck201712001 |
[2]
|
Stewart EA. Uterine fibroids[J]. Lancet, 2001, 357:293-298. doi: 10.1016/S0140-6736(00)03622-9 |
[3]
|
Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up[J]. BJOG, 2002, 109:1262-1272. doi: 10.1046/j.1471-0528.2002.01449.x |
[4]
|
张俊海, 刘晓霞, 熊海芮, 等.磁共振引导超声聚焦治疗子宫肌瘤患者的MRI筛选[J].中国医学计算机成像杂志, 2017, 23:539-543. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxjsjcx201706011 |
[5]
|
苏佰燕, 范融, 薛华丹, 等.MR引导下聚焦超声术治疗症状性子宫肌瘤的安全性及有效性[J].中华放射学杂志, 2017, 51:149-153. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfsx201702015 |
[6]
|
吴光耀, 董国礼, 杨汉丰, 等.MR引导高强度聚焦超声治疗子宫肌瘤的Meta分析[J].中华放射学杂志, 2015, 49:391-394. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfsx201505018 |
[7]
|
薛华丹, 苏佰燕, 范融, 等.MR引导下聚焦超声术治疗症状性子宫肌瘤安全性及有效性的初步研究[J].中华放射学杂志, 2012, 46:851-853. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfsx201209017 |
[8]
|
Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2 weighted magnetic resonance images[J]. Am J Obstet Gynecol, 2007, 196:184.e1-e6. doi: 10.1016/j.ajog.2006.08.030 |
[9]
|
Zhao WP, Chen JY, Zhang L, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging[J]. Eur J Radiol, 2013, 82:e43-e49. doi: 10.1016/j.ejrad.2012.08.020 |
[10]
|
Mikami K, Murakami T, Okada A, et al. Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience[J]. Radiat Med, 2008, 26:198-205. doi: 10.1007/s11604-007-0215-6 |
[11]
|
Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm[J]. J Appl Physiol, 1948, 1:93-122. doi: 10.1152/jappl.1948.1.2.93 |
[12]
|
Kim YS, Lim HK, Kim JH, et al. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids[J]. Invest Radiol, 2011, 46:639-647. doi: 10.1097/RLI.0b013e318220785c |
[13]
|
Kim YS, Kim TJ, Lim HK, et al. Preservation of the endometrial enhancement after magnetic ultrasound ablation of submucosal uterine fibroids[J]. Eur Radiol, 2017, 27:3956-3965. doi: 10.1007/s00330-017-4765-4 |
[14]
|
Pron G. Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis[J]. Ont Health Technol Assess Ser, 2015, 15:1-86. http://europepmc.org/articles/PMC4558769 |
[15]
|
Park MJ, Kim YS, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy[J]. J Vasc Interv Radiol, 2014, 25:231-239. doi: 10.1016/j.jvir.2013.11.011 |
[16]
|
Yoon SW, Seong SJ, Jung SG, et al. Mitigation of abdominal scars during MR-guided high-intensity focused ultrasound treatment of uterine leiomyomas with the use of an energy-blocking scar patch[J]. J Vasc Interv Radiol, 2011, 22:1747-1750. doi: 10.1016/j.jvir.2011.07.005 |
[17]
|
Chen R, Keserci B, Bi H, et al. The safety and effectiveness of volumetric magnetic resonance-guided high intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China[J]. J Ther Ultrasound, 2016, 4:27. doi: 10.1186/s40349-016-0072-9 |
[18]
|
Park MJ, Kim YS, Rhim H, et al. Technique to displace bowel loops in MRI-guided high-intensity focused ultrasound ablation of fibroids in the anteverted or anteflexed uterus[J]. AJR Am J Roentgenol, 2013, 201:W761-W764. doi: 10.2214/AJR.12.10081 |
[19]
|
Duc NM, Keserci B. Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids[J]. Diagn Interv Radiol, 2018, 24:283-291. doi: 10.5152/dir.2018.18111 |
[20]
|
Machtinger R, Inbar Y, Cohen-Eylon S, et al. MR-guided focus ultrasound (MRgFUS) for symptomatic uterine fibroids: predictors of treatment success[J]. Hum Reprod, 2012, 27:3425-3431. doi: 10.1093/humrep/des333 |
[21]
|
Park H, Yoon SW, Sokolov A. Scaled signal intensity of uterine fibroids based on T2-weighted MR images: a potential objective method to determine the suitability for magnetic resonance-guided focused ultrasound surgery of uterine fibroids[J]. Eur Radiol, 2015, 25:3455-3458. doi: 10.1007/s00330-015-3806-0 |
[22]
|
Yoon SW, Lee C, Cha SH, et al. Patient selection guidelines in MR-guided focused ultrasound surgery of uterine fibroids: a pictorial guide to relevant findings in screening pelvic MRI[J]. Eur Radiol, 2008, 18:2997-3006. doi: 10.1007/s00330-008-1086-7 |
[23]
|
Rueff LE, Raman SS. Clinical and technical aspects of MR-guided high intensity focused ultrasound for treatment of symptomatic uterine fibroids[J]. Semin Intervent Radiol, 2013, 30:347-353. doi: 10.1055/s-0033-1359728 |
[24]
|
Quinn SD, Vedelago J, Gedroyc W, et al. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 182:243-247. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=f53aa45965e67b6ac19a8f45a5d00444 |
[25]
|
Ticca C, Bignardi T, Zucconi F, et al. Efficacy of MR-guided focused ultrasound surgery (MRgFUS) of uterine fibroids: evaluation of non perfused volume (NPV), fibroid shrinkage and clinical improvement at 6 months follow-up[J]. Transl Cancer Res, 2014, 3:413-420. http://www.researchgate.net/publication/301633770_Efficacy_of_MR-guided_focused_ultrasound_surgery_MRgFUS_of_uterine_fibroids_Evaluation_of_non_perfused_volume_NPV_fibroid_shrinkage_and_clinical_improvement_at_6_months_follow-up |
[26]
|
Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre[J]. Eur Radiol, 2015, 25:1317-1328. doi: 10.1007/s00330-014-3538-6 |
[27]
|
Sridhar D, Kohi MP. Updates on MR-guided focused ultrasound for symptomatic uterine fibroids[J]. Semin Intervent Radiol, 2018, 35:17-22. doi: 10.1055/s-0038-1636516 |
[28]
|
Mashiach R, Inbar Y, Rabinovici J, et al. Outcome of magnetic resonance-guided focused ultrasound surgery (MRgFUS) for FIGO class 1 fibroids[J]. Eur J Obstet Gynecol Reprod Biol, 2018, 221:119-122. doi: 10.1016/j.ejogrb.2017.12.025 |
[29]
|
Mascaretti S, Ferrari F, Miccoli A, et al. Feasibility of magnetic resonance-guided focus ultrasound surgery (MRgFUS) in the uterine fibroid treatment: evaluation of the treatment radicalization in single and multiple fibroids correlated to clinical outcome[J]. Clin Exp Obstet Gynecol, 2018, 45:84-87. http://smartsearch.nstl.gov.cn/paper_detail.html?id=53c46ce3284fa40ce89e12130b5aa394 |
[30]
|
Fukunishi H, Funaki K, Sawada K, et al. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases[J]. J Minim Invasive Gynecol, 2008, 15:571-579. doi: 10.1016/j.jmig.2008.06.010 |
[31]
|
Ferrari F, Arrigoni F, Miccoli A, et al. Effectiveness of magnetic resonance-guided focused ultrasound surgery (MRgFUS) in the uterine adenomyosis treatment: technical approach and MRI evaluation[J]. Radiol Med, 2016, 121:153-161. doi: 10.1007/s11547-015-0580-7 |
[32]
|
Polina L, Nyapathy V, Mishra A, et al. Noninvasive treatment of focal adenomyosis with MR-guided focused ultrasound in two patients[J]. Indian J Radiol Imaging, 2012, 22: 93-97. doi: 10.4103/0971-3026.101078 |